New hope for wrinkles

Dec 15, 2006

A new anti-aging ingredient developed by Australian researchers is expected to be available in skin products next year. The new additive - gamma glutamyl cysteine (GGC) - is a precursor for an effective antioxidant known as glutathione, which has a broad range of potential health benefits.

Glutathione is the body's key defense for detoxifying harmful compounds implicated in cancer, diabetes, aging along with other diseases and degenerative conditions.

After nine years in development, researchers Dr Wallace Bridge and Dr Martin Zarka, of the University of New Sotuh Wales (Sydney, Australia) have established a new, cost-effective process for manufacturing GGC.

The process has been licensed to pharmaceutical company, Biospecialties Australia. A newly-expanded manufacturing plant at Newcastle, New South Wales, will produce GGC.

It is expected that GGC will be used as an active ingredient in foods, health care, toothpastes, dietary supplements and cosmetics as well as in skin repair anti-aging creams.

Natural dietary sources of GGC are available, including milk whey protein and garlic.

However, GGC is present only in relatively dilute concentrations. This new, pure GGC product will potentially allow for more efficacious dosages and product formulations.

Given the rapidly increasing interest in glutathione, it is likely a pure GGC supplement would have significant market potential.

Biospecialties Australia P/L is a licensee of New South Innovations (NSi), which provides technology transfer services to the university.

The company received an Australian Government "Commercial Ready" grant of A$1.1M earlier this year to assist in bringing GGC to market for use in foods, health care and cosmetics.

Source: University of New South Wales

Explore further: Use new meningitis vaccines only for outbreaks

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Use new meningitis vaccines only for outbreaks

6 hours ago

(AP)—A U.S. panel on Thursday recommended that two new meningitis vaccines only be used for rare outbreaks, resisting tearful pleas to give it routinely to teens and college students.

New antibiotic avycaz approved

10 hours ago

(HealthDay)—The combination antibiotic Avycaz (ceftazidime-avibactam) has been approved by the U.S. Food and Drug Administration to treat adults with complicated infections of the intra-abdominal area or urinary tract, ...

Tagging drugs to fight counterfeit medicines

Feb 25, 2015

The U.S. and other countries are enacting rules to clamp down on the sales of fake pharmaceuticals, which pose a public health threat. But figuring out a system to track and authenticate legitimate drugs still faces significant ...

Watchdog group seeks FDA ban of antifungal tablets

Feb 24, 2015

(AP)—A consumer safety group is calling on the Food and Drug Administration to pull certain antifungal tablets off the market, saying there are safer medicines that do not carry risks of liver damage.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.